Chemical engineering alumnus James (Jim) Robinson ’82 ’84G is using his wealth of biopharma experience to assist in the development and production of a COVID-19 vaccine.
Robinson is the scientific advisory board vice-chair for the Coalition for Epidemic Preparedness Innovation (CEPI) and principal of James Robinson Biologics Consulting. His expertise in vaccine production is the result of a career that has included over 30 years at Sanofi Pasteur, Novavax, and Merck, developing and manufacturing vaccines, including vaccines for epidemic use for Asian avian influenza A (H5N1), swine flu (H1N1), SARS coronavirus (SARS-CoV), and Ebola.
Now, he is assisting CEPI with its mission to accelerate COVID-19 vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale.
At 12:30 pm ET, Wednesday, June 17, Robinson will participate in a Mountain Talk, a 30-minute video chat with experts in the Lehigh community The webinar will help viewers get a better understanding of the monumental effort taking place behind the scenes of the COVID-19 vaccine discovery and production.
Visit the Mountain Talks home page to register for the live webinar or to receive a link to the recording.
